USA flag logo/image

An Official Website of the United States Government

Rapid, noninvasive diagnosis and monitoring of shock

Award Information

Department of Health and Human Services
Award ID:
Program Year/Program:
2010 / STTR
Agency Tracking Number:
Solicitation Year:
Solicitation Topic Code:
Solicitation Number:
Small Business Information
1700 THE STRAND, STE 1.200 GALVESTON, TX 77555-2240
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Phase 1
Fiscal Year: 2010
Title: Rapid, noninvasive diagnosis and monitoring of shock
Agency: HHS
Contract: 1R41HL103095-01
Award Amount: $162,065.00


DESCRIPTION (provided by applicant): Assessment and management of circulatory shock in critically ill patients requires rapid measurement of two critical variables: mixed venous oxyhemoglobin saturation (venous SO2) and total blood hemoglobin concentration[Hgb] to identify insufficient oxygen delivery and anemia and to determine the need for therapy with fluids, inotropic or vasodilator drugs or blood transfusion. Current invasive techniques for measurement of venous SO2 and [Hgb] require central venous orpulmonary arterial catheterization and blood sampling. In emergency department patients with septic shock, management based on maintaining venous SO2 at e 70%, as measured invasively in the superior vena cava, reduced mortality from 46.5% to 30.5%. At present, no available noninvasive technique measures venous SO2 and [Hgb] to guide treatment. Our research team has pioneered optoacoustic imaging techniques for accurate, non-invasive, real-time measurement of SO2 and [Hgb]. We designed, built, and performedin vitro and in vivo testing of a novel, compact, high-resolution optoacoustic imaging system that measures SO2 and [Hgb] directly from blood vessels. The optoacoustic imaging is based on generation of ultrasonic (optoacoustic) waves by near infra-red laser light pulses and detection of optoacoustic waves by a sensitive wide-band acoustic transducer. Optoacoustic waves are linearly dependent on SO2 and [Hgb]. Our in vitro and in vivo tests of the system with optoacoustic probes demonstrated that the systemis capable of measuring oxygenation and [Hgb] measurement with high accuracy approaching that of the CO-Oximeter, the conventional gold standard method for measuring oxygen saturation in blood. In this application, our multidisciplinary team of bioengineers and intensivists proposes to develop and test novel, highly-portable clinical, prototype with unique capabilities for rapid, noninvasive assessment and management of circulatory shock in surgical and critically ill patients. PUBLIC HEALTH RELEVANCE: The proposed project will have a substantial impact on care of patients undergoing surgery, critically ill patients, and patients in shock. The proposed optoacoustic system will replace invasive, intermittent diagnostic testing of central venous bloodoxygenation hemoglobin with noninvasive, rapid, and continuous monitoring.

Principal Investigator:

Donald S. Prough

Business Contact:

Donald S. Prough
Small Business Information at Submission:

1700 THE STRAND, STE 1.200 GALVESTON, TX 77555-2240

EIN/Tax ID: 126031962
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
University Of Texas Medical Br Galveston
301 University Blvd